Literature DB >> 26017584

The Role of B-Vitamins in Bone Health and Disease in Older Adults.

Regan L Bailey1, Janneke P van Wijngaarden.   

Abstract

The risk of osteoporosis and bone fractures increases with age. Several other factors are also related to bone disease including gender, race/ethnicity, physical activity, alcohol, smoking, estrogen, and calcium and vitamin D. B-vitamins (folate, B12, and B6) are also emerging dietary factors related to bone health, both individually and through their action on influencing total plasma homocysteine concentrations (tHcy). The primary objective of this review is to summarize the available data on B-vitamins and bone health, highlighting clinical trials and observational data. In populations without folic acid fortification, the totality of evidence suggests that elevated tHcy has a small but significant association with bone fracture risk and bone quality but not on bone mineral density (BMD) or bone turnover biomarkers. Very little supportive evidence exists for a direct role of folate for either BMD or fracture risk; however, the data available are quite limited. Meta-analyses and some cross-sectional and cohort studies suggest a small but significant role of vitamin B12 status on risk of fracture but not on BMD. The mechanism by which tHcy and B12 may influence bone health is not well characterized but may be through modulation of collagen cross-linking or through altering osteoclasts or osteoblasts. Much more data are needed-particularly the role that each vitamin directly has on bone, or whether the vitamins only exert their effect though tHcy concentrations. Nevertheless, consistent findings across different populations with different study designs suggest a role for tHcy and B12 in reducing fracture risk.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26017584     DOI: 10.1007/s11914-015-0273-0

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  59 in total

1.  Randomized clinical trial of homocysteine level lowering therapy and fractures.

Authors:  Anna M Sawka; Joel G Ray; Qilong Yi; Robert G Josse; Eva Lonn
Journal:  Arch Intern Med       Date:  2007-10-22

2.  Effect of vitamin B6 deficiency on collagen metabolism in rats.

Authors:  N Tane; T Takeda; T Shioji; H Ohyama; H Itoh
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1976       Impact factor: 2.000

3.  Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans.

Authors:  Martha Savaria Morris; Paul F Jacques; Jacob Selhub
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

Review 4.  The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.

Authors:  Helga Refsum; Eha Nurk; A David Smith; Per M Ueland; Clara G Gjesdal; Ingvar Bjelland; Aage Tverdal; Grethe S Tell; Ottar Nygård; Stein E Vollset
Journal:  J Nutr       Date:  2006-06       Impact factor: 4.798

5.  Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study.

Authors:  Clara Gram Gjesdal; Stein Emil Vollset; Per Magne Ueland; Helga Refsum; Christian A Drevon; Håkon K Gjessing; Grethe S Tell
Journal:  Arch Intern Med       Date:  2006-01-09

6.  Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.

Authors:  Yoshihiro Sato; Yoshiaki Honda; Jun Iwamoto; Tomohiro Kanoko; Kei Satoh
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

7.  Vitamin B-12 supplementation of rural Mexican women changes biochemical vitamin B-12 status indicators but does not affect hematology or a bone turnover marker.

Authors:  Setareh Shahab-Ferdows; Miriam A Anaya-Loyola; Haydé Vergara-Castañeda; Jorge L Rosado; William R Keyes; John W Newman; Joshua W Miller; Lindsay H Allen
Journal:  J Nutr       Date:  2012-08-22       Impact factor: 4.798

8.  Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans.

Authors:  Joerg H Holstein; Markus Herrmann; Christina Splett; Wolfgang Herrmann; Patric Garcia; Tina Histing; Stefan Graeber; Mei Fang Ong; Karsten Kurz; Thomas Siebel; Michael D Menger; Tim Pohlemann
Journal:  Am J Clin Nutr       Date:  2009-09-16       Impact factor: 7.045

9.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

10.  The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women.

Authors:  K Zhu; J Beilby; I M Dick; A Devine; M Soós; R L Prince
Journal:  Osteoporos Int       Date:  2008-11-27       Impact factor: 4.507

View more
  7 in total

1.  Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?

Authors:  T Sugiyama; K Watarai; T Oda; Y T Kim; H Oda
Journal:  Osteoporos Int       Date:  2016-02-09       Impact factor: 4.507

2.  Effect of Combination Folic Acid, Vitamin B6 , and Vitamin B12 Supplementation on Fracture Risk in Women: A Randomized, Controlled Trial.

Authors:  Katie L Stone; Li-Yung Lui; William G Christen; Aron M Troen; Douglas C Bauer; Deborah Kado; Christopher Schambach; Steven R Cummings; JoAnn E Manson
Journal:  J Bone Miner Res       Date:  2017-12       Impact factor: 6.741

3.  Risk of hip fracture in meat-eaters, pescatarians, and vegetarians: results from the UK Women's Cohort Study.

Authors:  Darren C Greenwood; Janet E Cade; James Webster
Journal:  BMC Med       Date:  2022-08-11       Impact factor: 11.150

4.  Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?

Authors:  Kristin M Aasarød; Mats P Mosti; Malin T Finstad; Astrid K Stunes; Reidar Fossmark; Unni Syversen
Journal:  Bone Rep       Date:  2021-05-20

5.  Bone density and depressive disorder: a meta-analysis.

Authors:  Julietta Ursula Schweiger; Ulrich Schweiger; Michael Hüppe; Kai G Kahl; Wiebke Greggersen; Eva Fassbinder
Journal:  Brain Behav       Date:  2016-05-18       Impact factor: 2.708

6.  The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.

Authors:  Julietta Ursula Schweiger; Ulrich Schweiger; Michael Hüppe; Kai G Kahl; Wiebke Greggersen; Kamila Jauch-Chara; Eva Fassbinder
Journal:  Int J Environ Res Public Health       Date:  2018-06-30       Impact factor: 3.390

7.  Hyperhomocysteinemia is Associated with Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women with Decreased Bone Mineral Density.

Authors:  Massimo De Martinis; Maria Maddalena Sirufo; Cristina Nocelli; Lara Fontanella; Lia Ginaldi
Journal:  Int J Environ Res Public Health       Date:  2020-06-15       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.